JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Jason D souza as Executive Vice President of the Company w.e.f. March 06, 2026.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Jason D'souza has resigned as Executive Vice President of JB Chemicals & Pharmaceuticals, with effect from the close of business hours on March 6, 2026. The company stated the intimation to the stock exchanges was delayed due to inadvertence, and this filing is a fresh corporate announcement in response to a BSE email. The resignation letter has been enclosed, and the disclosure is being made under SEBI Listing Regulations. No reasons for the resignation were disclosed beyond the standard 'resignation' classification.
This is a routine senior management-level exit with no indication of governance issues or financial concerns. Shareholders are unlikely to see a material impact on the stock, though investors may watch for any follow-up disclosures on succession planning for the EVP role.